TWD
ALDX icon

True Wealth Design’s Aldeyra Therapeutics ALDX Stock Holding History

True Wealth Design’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665 Buy
312
+154
+97% +$265 ﹤0.01% 2109
2026
Q1 		$268 Sell
158
-16
-9% -$70 ﹤0.01% 2256
2025
Q4 		$902 Sell
174
-56
-24% -$288 ﹤0.01% 1745
2025
Q3 		$1.2K Buy
230
+83
+56% +$433 ﹤0.01% 1693
2025
Q2 		$564 Sell
147
-96
-40% -$248 ﹤0.01% 1696
2025
Q1 		$1.4K Buy
243
+223
+1,115% +$1.32K ﹤0.01% 1140
2024
Q4 		$100 Buy
+20
New +$103 ﹤0.01% 1275

Other funds holding ALDX

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design's ALDX Position: Q2 2026 in Review

True Wealth Design increased its Aldeyra Therapeutics (ALDX) stake by 97% in Q2 2026, buying an estimated $265 and bringing the position to 312 shares worth $665. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

True Wealth Design first reported a position in ALDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.4K in Q1 2025. 10 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • True Wealth Design held 312 shares of Aldeyra Therapeutics worth $665 as of Q2 2026.
  • True Wealth Design bought 154 Aldeyra Therapeutics shares in Q2 2026, an estimated $265.
  • Aldeyra Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2109 holding.
  • True Wealth Design first reported a position in Aldeyra Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • True Wealth Design's Aldeyra Therapeutics position peaked at $1.4K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.